+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The changing gastrointestinal side effect profile of non-steroidal anti-inflammatory drugs. A new approach for the prevention of a new problem



The changing gastrointestinal side effect profile of non-steroidal anti-inflammatory drugs. A new approach for the prevention of a new problem



Scandinavian Journal of Gastroenterology. Suppl. 163: 56-64



The most serious side effects of non-steroidal anti-inflammatory drugs (NSAIDs) involve gastroduodenal perforations and massive haemorrhage. It is becoming increasingly clear, however, that it is the small intestine that bears the main brunt of NSAID-related gastrointestinal toxicity. Hence 70% of patients receiving NSAIDs in the long term have evidence of small-intestinal inflammation, and the same patients lose blood and protein as a consequence. Many patients have asymptomatic ileal dysfunction and occasionally may develop unique small-intestinal strictures necesitating surgery. The pathogenesis of the intestinal inflammation is beginning to emerge. There are data to support that an imbalance between prostaglandins and leukotrienes is important in disrupting small-intestinal integrity during drug absorption. Furthermore, a simple mixture of glucose and citrate with indomethacin appears to minimize the damage. Whether this overcomes a metabolic block caused by NSAIDs and replenishes ATP levels or acts by scavenging oxygen free radicals is unknown, but our further understanding of the mechanism may revolutionize our approach to prevention of the gastrointestinal toxicity of NSAIDs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041588740

Download citation: RISBibTeXText

PMID: 2683029

DOI: 10.3109/00365528909091176


Related references

Gastrointestinal tract disorder as a side effect of non-steroidal anti inflammatory drugs (NSAIDs). Acta Medica Indonesiana 36(4): 195-196, 2005

Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Alimentary Pharmacology and Therapeutics 20 Suppl 2: 48-58, 2004

Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract. Current Medicinal Chemistry 7(11): 1121-1129, 2000

Upper gastrointestinal bleeding and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose aspirin. Alimentary Pharmacology and Therapeutics 26(8): 1171-1178, 2007

Review article: non-steroidal, anti-inflammatory drugs--the extending scope of gastrointestinal side effects. Alimentary Pharmacology and Therapeutics 6(2): 143-162, 1992

Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Journal of Pharmacy and Pharmacology 58(10): 1295-1304, 2006

Non-steroidal anti-inflammatory drugs and gastrointestinal disease: is there a better approach to NSAID use?. Italian Journal of Gastroenterology and Hepatology 30(2): 139-142, 1998

Gastrointestinal side effects of non-steroidal anti-inflammatory drugs in high-risk patients--role of selective cyclooxygenase inhibitors. Orvosi Hetilap 142(35): 1899-1905, 2001

Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: The effect of nimesulide compared with naproxen on the human gastrointestinal tract. Rheumatology 38(SUPPL 1): 24-32, 1999

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ 329(7472): 948, 2004

Cimetidine tablets or suspension for the prevention of gastrointestinal mucosal lesions caused by non-steroidal, anti-inflammatory drugs. Scandinavian Journal of Rheumatology 18(6): 369-375, 1989

Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs). American Journal of Medicine 107(6a): 27s-35s; Discussion 35s-36s, 2000

Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs). American Journal of Medicine 107(6 part A): 27S-36S, 1999

Nitric oxide-releasing non-steroidal anti-inflammatory drugs: a novel approach for reducing gastrointestinal toxicity. Journal of Gastroenterology and Hepatology 9 Suppl 1: S40-S44, 1994

Lead optimization on conventional non-steroidal anti-inflammatory drugs: an approach to reduce gastrointestinal toxicity. Chemical Biology and Drug Design 84(1): 1-23, 2015